StreetAlpha.app
Home › Stocks › CDXS

Codexis, Inc. (CDXS)

$1.01
▼ −3.81%
LAST CLOSE · NOV 20

Codexis makes engineered enzymes and manufacturing services that help pharmaceutical companies produce drug therapeutics. It last closed at $1.01 on Nov 20, down 3.81% on the day. The next earnings report for CDXS is expected around Wed, Mar 10, 2027, after the close. For the quarter ended Sep 2026, CDXS reported EPS of -$0.08 on revenue of $19.3M, with revenue up 124.0% from a year ago. Over its last 8 reports the stock moved an average of 16.8% the session after earnings. Over the last 12 months CDXS insiders bought $0 of stock on the open market and sold $699K, according to SEC Form 4 filings.

AI Auto Pilots
Is CDXS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CDXS.

Key Stats

Last 12 months
Results
Revenue
$88.3M
+66.9% vs a year ago
Net income
−$19.2M
−21.8% margin
EPS (diluted)
−$0.18
Free cash flow
−$12.1M
−13.7% margin
Valuation
Market cap
$110.7M
109.6M shares
P/E
–
No P/E while losing money
Price to sales
1.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$29.2M
At Sep 30
Debt
$41.3M
At Sep 30
Shareholder equity
$51.2M
Shares outstanding
109.6M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $104.8M$104.8MFY2021FY2022: $138.6M$138.6MFY2022FY2023: $70.1M$70.1MFY2023FY2024: $59.3M$59.3MFY2024FY2025: $70.4M$70.4MFY2025

From CDXS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Mar 10
Estimated date · After the close
Reported EPS
-$0.08
Quarter ended Sep 2026
Year ago EPS
-$0.22
Same quarter last year
Revenue
$19.3M
+124.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.11Dec '24Mar 2025: -$0.25Mar '25Jun 2025: -$0.16Jun '25Sep 2025: -$0.22Sep '25Dec 2025: $0.12Dec '25Mar 2026: -$0.10Mar '26Jun 2026: -$0.13Jun '26Sep 2026: -$0.08Sep '26Latest -$0.08
Revenue by quarter
Dec 2024: $21.5MDec '24Mar 2025: $7.5MMar '25Jun 2025: $15.3MJun '25Sep 2025: $8.6MSep '25Dec 2025: $38.9MDec '25Mar 2026: $15.2MMar '26Jun 2026: $14.9MJun '26Sep 2026: $19.3MSep '26Latest $19.3M
How CDXS moved after its last 8 reports
Average move the session after a report ±16.8%
Nov 12, 2026After the close+21.1%
Jul 23, 2026After the close−25.6%
May 7, 2026After the close+10.5%
Mar 11, 2026After the close+34.6%
Nov 6, 2025After the close−16.9%
Aug 13, 2025After the close+1.6%
May 14, 2025After the close+1.6%
Feb 27, 2025After the close−22.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CDXSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CDXS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CDXS

Technical Analysis

CDXS · as of the Nov 20 close · updated each morning
Downtrend

The stock is 9% below its 20 day and 24% below its 50 day average. It is 77% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 41). The nearest support is the swing low (Nov 5) at $0.99, and the nearest resistance the Pivot at $1.02.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 9.8%/day
Key levels
$2.9852 week high+195.0%
$1.78200 day average+76.2%
$1.51100 day average+49.5%
$1.2550 day average+23.8%
$1.17Swing high (Nov 9)+15.8%
$1.1020 day average+8.9%
$1.05Pivot R1+4.0%
$1.02Pivot+1.0%
$1.01Last close
$0.99Swing low (Nov 5)−2.0%
$0.97Pivot S1−4.0%
$0.9052 week low−10.9%
Indicators
RSI (14)41.32Middle of its rangeNeutral
MACD-0.06Above its signal lineBullish
Stochastic52.4Middle of its rangeNeutral
ADX (14)30.9Trending down
Williams %R-63.3Oversold below −80, overbought above −20Neutral
CCI (20)-83.5Oversold below −100, overbought above 100Neutral
Rate of change−6.5%Change over 10 sessionsBearish
ATR (14)$0.10Typical daily range, 9.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CDXS

What happened before

See how CDXS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CDXS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CDXS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CDXSHow many large options trades hit CDXS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

CDXS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●74 buying vs 67 selling
  • ▲Held by funds +5.0 pts
  • ▼Funds holding -20
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding130150−13.3%
In funds' top 1000–
Held by funds68.6%63.7%+5.0 pts
New / increased16 / 5828 / 63−18.7%
Reduced / sold out32 / 3535 / 12+42.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CDXS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CDXS Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$699K12 sales · 6 insiders
2025-12 sold $620K2026-01 sold $8K2026-02 sold $20K2026-06 sold $6K2026-10 sold $17K2026-11 sold $13KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Alison MoorePresident and CEOSale10,651$1.14$12K
Nov 9Vre Raymond DeDirectorSale1,088$1.11$1K
Oct 12Alison MoorePresident and CEOSale6,335$1.36$9K
Oct 12Georgia ErbezSee RemarksSale6,335$1.36$9K
Jun 11Vre Raymond DeDirectorSale2,605$2.37$6K
Feb 24Stefan LutzChief Scientific OfficerSale5,862$1.13$7K
Every insider buy and sale for CDXS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CDXS insider trades →

From SEC Form 4 filings by CDXS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDXS is in one of them and how their past CDXS trades turned out.

CDXS in the AI portfolios
Loading…

CDXS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CDXS in an article yet. Here's the latest on the wider market.

CDXS in the news

CDXS Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed May 8
Who traded CDXS · since 2018
Latest 1 filing
$1K – $15KTraded Apr 6, 2018Filed May 8, 2018
PersonTypeAmountTradedFiledDelay
Lamar SmithR · TXBuy$1K – $15KApr 6, 2018May 8, 201832 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Codexis

Codexis develops engineered enzymes and other proteins that improve how drugs are made, using its CodeEvolver platform. Its ECO Synthesis platform uses enzymes to manufacture RNA interference therapeutics, and it offers method development, process development and manufacturing support to drug developers. Its small molecule business sells optimized enzymes to large pharmaceutical companies to raise yields and purity. The company is based in Redwood City, California.

Headquarters
Redwood City, CA
Founded
2002